Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05676255 · ClinicalTrials.gov registry record · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
A Phase 2 study of Breast Cancer Female and Psychological Distress, sponsored by University of Arizona.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 452
- Enrollment target
- 1
- Study location
NCT05676255: Recruiting Phase 2 study of Breast Cancer Female and Psychological Distress, sponsored by University of Arizona.
NCT05676255 is a Phase 2 study of Breast Cancer Female and Psychological Distress that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 452 participants, below the 683-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05676255, a Phase 2 study of Breast Cancer Female and Psychological Distress, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 452 participants
- Enrollment target
- 1
- Study location
Study Summary
Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments. This research will build on the rigor of prior research to reduce breast cancer survivor depression and anxiety with a compassion meditation intervention called CBCT (Cognitively-Based Compassion Training) for online synchronous delivery that is also inclusive of informal caregivers (i.e., adult family members who live with and typically provide half the care for survivors, aka supportive partners).
Primary Outcome
The difference in the change in depression features between the intervention arms from before to 8 weeks after start of the interventions will be measured with the Patient-Reported Outcomes Measurement Information System short form Depression - 8a.
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Cognitively-Based Compassion Training for Survivors
- BEHAVIORAL Cognitively-Based Compassion Training for Dyads
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2027-06 |
| Phase | Phase 2 |
What NCT05676255 shows while recruiting
NCT05676255 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 683-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (34% lower).
The record links to 2 conditions, with Breast Cancer Female appearing as the primary indexed condition, and to 3 interventions - of which Health Education is the first listed.
NCT05676255 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05676255 about?
NCT05676255 is a clinical study titled "The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project". Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments. This research will build on the rigor of prior research to reduce breast cancer survivor depression and anxiety with a c...
What is the current status of trial NCT05676255?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 452 participants. The study started on 2023-03-20. Estimated completion is 2027-06.
What conditions does trial NCT05676255 study?
This clinical trial studies the following conditions: Breast Cancer Female, Psychological Distress.
What interventions are being tested in trial NCT05676255?
The interventions under investigation include: Health Education (BEHAVIORAL), Cognitively-Based Compassion Training for Survivors (BEHAVIORAL), Cognitively-Based Compassion Training for Dyads (BEHAVIORAL).
Who is sponsoring clinical trial NCT05676255?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05676255 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05676255's enrollment target sits among peer trials
452 9th of 46 higher than 38 of 46 other Breast Cancer Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
RECRUITING · Phase 2
-
Microbiome and Association With Implant Infections
RECRUITING · Phase 2
-
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
RECRUITING · Phase 2
-
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
ACTIVE NOT RECRUITING · Phase 2
-
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI